These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35065856)

  • 1. Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine.
    J Emerg Med; 2022 Mar; 62(3):426. PubMed ID: 35065856
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
    Badoiu A; Moranne O; Coudray S; Ion IM
    J Clin Neuromuscul Dis; 2021 Dec; 23(2):115-116. PubMed ID: 34808658
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
    Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
    Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination.
    Aomar-Millán IF; Martínez de Victoria-Carazo J; Peregrina-Rivas JA; Villegas-Rodríguez I
    Rev Clin Esp (Barc); 2021 Nov; 221(9):555-557. PubMed ID: 34593364
    [No Abstract]   [Full Text] [Related]  

  • 5. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
    Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
    Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
    Masuccio FG; Comi C; Solaro C
    Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
    [No Abstract]   [Full Text] [Related]  

  • 7. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
    García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
    Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilateral facial palsy after COVID-19 vaccination.
    Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
    Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
    Renoud L; Khouri C; Revol B; Lepelley M; Perez J; Roustit M; Cracowski JL
    JAMA Intern Med; 2021 Sep; 181(9):1243-1245. PubMed ID: 33904857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis.
    Pegat A; Vogrig A; Khouri C; Masmoudi K; Vial T; Bernard E
    Ann Neurol; 2022 Jan; 91(1):162-163. PubMed ID: 34699065
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to 'Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis' by Dr Pegat et al.
    Maramattom BV
    Ann Neurol; 2022 Jan; 91(1):163. PubMed ID: 34704270
    [No Abstract]   [Full Text] [Related]  

  • 15. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain-Barre syndrome following the first dose?
    Finsterer J
    Indian J Public Health; 2022; 66(3):385-386. PubMed ID: 36149133
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Before SARS-CoV-2 Vaccine is Held Responsible for Guillain-Barre Syndrome, Other Causes Must be Removed From the Table.
    Finsterer J
    J Clin Neuromuscul Dis; 2024 Mar; 25(3):146-148. PubMed ID: 38441933
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients.
    Tayebi A; Samimisedeh P; Jafari Afshar E; Mahmoudnia S; Milan N; Ayati A; Madady A; Rastad H
    BMC Neurol; 2023 Dec; 23(1):437. PubMed ID: 38082244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.